Results of MRD analysis in the GITMO/IIL trial. (A) Results of screening for molecular markers and assignment of evaluable patients to treatment arm. (B) MR in the whole patient population and in CHOP-R and R-HDS patients. (C) PFS according to the presence of MR (PCR−) or lack of MR (PCR+). (D) PFS according to treatment arm in patients achieving MR. (E) PFS according to treatment arm in patients not achieving MR.